EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Randomisierte kontrollierte Studie

Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age

Mark J Bolland iD, Zaynah Nisa, Anna Mellar, Chiara Gasteiger, Veronica Pinel, Borislav Mihov, Sonja Bastin, Andrew Grey, Ian R Reid iD, Greg Gamble, Anne Horne

New England Journal of Medicine · 16.01.2025 · 392 (3) · 239-248

DOI: 10.1056/nejmoa2407031 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, erschienen am 16.01.2025. Verfasst von Mark J Bolland und 10 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Medicine, University of Auckland, Auckland, New Zealand (M.J.B., Z.N., A.M., C.G., V.P., B.M., A.G., I.R.R., G.G., A.H.); the …. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Osteoporosis, Postmenopausal, Osteoporotic Fractures, Zoledronic Acid. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Health Research Council of New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsOsteoporosis, PostmenopausalOsteoporotic FracturesZoledronic AcidFemaleHumansMiddle AgedBone DensityDouble-Blind MethodDrug Administration ScheduleFollow-Up StudiesHip FracturesInfusions, IntravenousLumbar VertebraeProspective StudiesSpinal FracturesFemur Neck

Substanzen

Bone Density Conservation AgentsZoledronic Acid

Autor:innen und Institutionen

  • From the Department of Medicine, University of Auckland, Auckland, New Zealand (M.J.B., Z.N., A.M., C.G., V.P., B.M., A.G., I.R.R., G.G., A.H.); the Department of Psychology, Stanford University, Stanford, CA (C.G.); an…

ORCID-Profile: Mark J Bolland, Ian R Reid

Förderung

  • Health Research Council of New Zealand

Zitieren

APA

Bolland, M. J., Nisa, Z., Mellar, A., Gasteiger, C., Pinel, V., Mihov, B., Bastin, S., Grey, A., Reid, I. R., Gamble, G., & Horne, A. (2025). Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age. New England Journal of Medicine, 392(3), 239-248. https://doi.org/10.1056/nejmoa2407031

Vancouver

Bolland MJ, Nisa Z, Mellar A, Gasteiger C, Pinel V, Mihov B, et al. Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age. New England Journal of Medicine. 2025;392(3):239-248. doi:10.1056/nejmoa2407031

BibTeX
@article{Bolland2025,
  author = {Bolland, Mark J and Nisa, Zaynah and Mellar, Anna and Gasteiger, Chiara and Pinel, Veronica and Mihov, Borislav and Bastin, Sonja and Grey, Andrew and Reid, Ian R and Gamble, Greg and Horne, Anne},
  title = {Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {3},
  pages = {239--248},
  doi = {10.1056/nejmoa2407031}
}
Kostenlos starten →